Myogen files $125 million shelf

New York, June 3 - Myogen, Inc. registered a $125 million shelf in an S-3 filing with the Securities and Exchange Commission Friday.

Included in the registration are common stock, preferred stock, depositary shares, debt securities and warrants. Securities may be issued as convertibles.

Also included in the S-3 are 2.5 million shares to be sold by shareholders.

Myogen, a Westminster, Colo.-based biopharmaceutical company, will use proceeds for general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.